Sonoma Pharmaceuticals, Inc. current report, 04 February 2010

SEC Filing Summary: Oculus Innovative Sciences, Inc.

Business Context and Reporting Period

This Form 8-K was filed by Oculus Innovative Sciences, Inc. on February 4, 2010. The report serves to announce the financial results for the fiscal quarter ended December 31, 2009. The filing references a press release (Exhibit 99.1) containing the full details of the results.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.

Material Changes

The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the referenced press release.

Investor Verification Checklist

  • Verify the specific revenue and net income figures for the quarter ended December 31, 2009, in the attached press release.
  • Confirm the company's cash position and liquidity status as of the reporting date.
  • Review management's commentary on the results and any updated guidance for the fiscal year 2010.
  • Check for any material changes in the company's operational status or regulatory environment mentioned in the press release.